Département
MEDICINA
Publications (54) Publications auxquelles un chercheur a participé
2021
-
A Cytometrist's Guide to Coordinating and Performing Effective COVID-19 Research
Cytometry Part A
-
A multifactorial aetiology for dilated cardiomyopathy
European Heart Journal - Case Reports
-
A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis
American Journal of Hematology
-
Areas of Specific Subspecialization (ACE) in Pulmonology
Archivos de Bronconeumologia
-
Areas of Specific Subspecialization (ACE) in pulmonology
Archivos de Bronconeumologia
-
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)
Scientific Reports
-
Authors reply to the letter to editor with regard to the article titled “Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping”
Cytometry Part B - Clinical Cytometry
-
C3G self-regulatory mechanism revealed: implications for hematopoietic malignancies
Molecular and Cellular Oncology
-
CIBERESUCICOVID: A strategic project for a better understanding and clinical management of COVID-19 in critical patients
Archivos de Bronconeumologia
-
COVID-19: What type of cytokine storm are we dealing with?
Journal of Medical Virology
-
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy
British Journal of Haematology
-
Catatonia with glycine receptor antibodies: Heads up?
Schizophrenia Research
-
Combined Procedure of Percutaneous Mitral Valve Repair and Left Atrial Appendage Occlusion: A Multicenter Study
JACC: Cardiovascular Interventions
-
Combining immunomodulators and antivirals for COVID-19 – Authors' reply
The Lancet Microbe
-
Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma (Annals of Hematology, (2020), 99, 8, (1793-1804), 10.1007/s00277-020-04149-5)
Annals of Hematology
-
Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)
Drugs
-
Correction to: Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML (Leukemia, (2021), 35, 7, (2119-2124), 10.1038/s41375-021-01125-4)
Leukemia
-
Correction to: Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir (Infectious Diseases and Therapy, (2021), 10, 4, (2203-2222), 10.1007/s40121-021-00455-1)
Infectious Diseases and Therapy
-
Correction to: SEOM clinical guidelines for the treatment of head and neck cancer (2020) (Clinical and Translational Oncology, (2021), 23, 5, (913-921), 10.1007/s12094-020-02533-1)
Clinical and Translational Oncology
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care